Expression of TNFα by CD3+ and F4/80+ cells following irradiation preconditioning and allogeneic spleen cell transplantation
- 15 December 2003
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (4) , 359-365
- https://doi.org/10.1038/sj.bmt.1704362
Abstract
The pathogenesis of acute graft-versus-host disease (aGVHD) includes tumor necrosis factor-alpha (TNF) expression by macrophages and T cells. However, the temporal comparison of donor vs host cells to TNF expression in response to irradiation conditioning and alloreactivity has not been reported. This study compared intracellular TNF expression in donor vs host spleen T cells and macrophages using a murine model of aGVHD. Total body irradiation conditioning alone resulted in increased frequency of F4/80+/TNF+ cells, but no increase in CD3+/TNF+ cells. Syngeneic transplantation resulted in an increased frequency of F4/80+/TNF+ cells, while CD3+/TNF+ cells increased on days 1 and 3 but declined on day 5. Allogeneic transplantation resulted in an increased frequency of donor CD3+/TNF+ cells, while the frequency of host CD3+/TNF+ cells declined. Similarly, donor F4/80+/TNF+ cells also increased in frequency after allotransplantation, while the frequency of host F4/80+/TNF+ cells was increased on day 1 and declined through days 3 and 5. In absolute cell numbers, CD3+/TNF+ cells were greater than F4/80+/TNF+ cells post allotransplantation. We conclude that (1) both donor and host CD3+ and F4/80+cells are present in the post transplant period and contribute to TNF production and (2) in terms of frequency, the majority of TNF producing cells in the spleen after allogeneic BMT are CD3+.Keywords
This publication has 25 references indexed in Scilit:
- Donor T cell–derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantationBlood, 2003
- Effects of NF-κB1 (p50) targeted gene disruption on ionizing radiation-induced NF-κB activation and TNFα, IL-1α, IL-1β and IL-6 mRNA expression in vivoInternational Journal of Radiation Biology, 2001
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Progressive Accumulation of Bacterial Lipopolysaccharide In Vivo During Murine Acute Graft‐Versus‐Host DiseaseScandinavian Journal of Immunology, 1997
- Induction of Tumor Necrosis Factor α Expression in Human T Lymphocytes Following Ionizing Gamma IrradiationJournal of Interferon & Cytokine Research, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.The Journal of Experimental Medicine, 1992
- Radioprotection by murine and human tumor‐necrosis factor: Dose‐dependent effects on hematopoiesis in the mouseEuropean Journal of Haematology, 1989
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.The Journal of Experimental Medicine, 1978